MARKET COMPOSITE
CI - Cigna Corp.8:00:02 PM 6/14/2024
Price
$333.29
-0.86 (-0.26%)
Cigna is an American worldwide health services organization based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups . Cigna is incorporated in Connecticut. Cigna offers Medicare and Medicaid products and health, life and accident insurance coverages primarily to individuals in the U.S. and selected international markets. In addition to its ongoing operations described above, Cigna also has certain run-off operations, including a Run-off Reinsurance segment. In the Phoenix metropolitan area, Cigna runs a full-service staff-model HMO with satellite clinics throughout the region, known as the Cigna Medical Group. Cigna Global Health Benefits also operates under the Cigna corporation.
Financials
Quarterly financials
(USD)Mar 2024Q/Q
Revenue57.3B+12%
Gross Profit15.8B-
Cost Of Revenue41.4B+17%
Operating Income2.3B+10%
Operating Expenses13.6B-
Net Income-212MM-119%
G&A3.7B-9%
Amortization423MM-6%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    Health insurers like UnitedHealth Group are seeking to control many parts of our healthcare system, creating potential conflicts of interest.

    For value investors looking to take a “break” from the euphoric technology stocks, many of which may have soared above and beyond your estimate of intrinsic value, the healthcare scene stands out as an intriguing place to bet on. Indeed, rotating cash from scorching-hot winners into some relatively lukewarm winners that are more attractively priced can make a lot of sense. Though I would not give up on tech, I would encourage investors to be more price-selective. You don’t need to pay a high-dou

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    Biden is campaigning on cutting drug costs for Medicare patients, but independent pharmacists say one strategy makes it unaffordable to keep some brand-name medicines in stock.

    We recently published a list of 10 Best Dividend Stocks to Buy According to Billionaire Leon Cooperman. Since Cigna Group (NYSE:CI) ranks 2nd in the list, it deserves a deeper look. Billionaire Leon Cooperman made headlines in April when he predicted during an interview with CNBC that the US is headed for a financial crisis. Cooperman, who calls […]

    The Cigna Group (NYSE:CI) recently announced a dividend of $1.4 per share, scheduled for payment on June 20, 2024, with the ex-dividend date set for June 4, 2024. As investors anticipate this upcoming disbursement, it's an opportune moment to delve into The Cigna Group's dividend history, yield, and growth rates, drawing on comprehensive data from GuruFocus to evaluate its sustainability. The Cigna Group primarily operates in pharmacy benefit management (PBM) and health insurance services.

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    More meetings and faceless chats. Fewer work friends. How the modern workday is fueling an epidemic of isolation.

    Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.

    Cigna’s massive pharmacy benefit manager has unveiled a new collaboration with a network of independent pharmacies at a time of rising tension between PBMs and the pharmacies they pay.